Novartis bids goodbye to Hudson, hello to new pharma chief Tschudin
Tschudin takes the baton from Hudson as Novartis revs up several new launches and builds out its portfolio in a half-dozen therapeutic fields while threading digital through its entire operation.
اقرأ المزيد